Your browser doesn't support javascript.
loading
Evaluation of risk factors for and subsequent mortality from poor graft function (PGF) post allogeneic stem cell transplantation.
Prabahran, Ashvind; Koldej, Rachel; Chee, Lynette; Wong, Eric; Ritchie, David.
Afiliação
  • Prabahran A; Department, of Clinical Haematology, Peter MacCallum Cancer/Royal Melbourne Hospital, Parkville, Australia.
  • Koldej R; Australian Cancer Research Fund Translational Research Laboratory, Royal Melbourne Hospital, Parkville, Australia.
  • Chee L; The University of Melbourne, Parkville, Australia.
  • Wong E; Australian Cancer Research Fund Translational Research Laboratory, Royal Melbourne Hospital, Parkville, Australia.
  • Ritchie D; The University of Melbourne, Parkville, Australia.
Leuk Lymphoma ; 62(6): 1482-1489, 2021 06.
Article em En | MEDLINE | ID: mdl-33522344
ABSTRACT
Poor Graft Function (PGF) is defined by multi-lineage cytopenias with complete donor chimerism post allogeneic transplantation, Risk factors for and subsequent mortality from PGF were assessed in our transplant cohort. Non-sibling donor [OR 1.97; 95% CI 1.02-3.70], ICU admission [OR 5.28; 95% CI 2.29-11.88] or blood culture positivity within the first 30 days [OR 1.67; 95% CI 1.07-2.62], grade III-IV acute graft vs host disease (GVHD) [OR 4.082; 95% CI 2.31-7.16] and CMV viremia [OR 2.43; 95% CI 1.53-3.88] and were significantly associated with development of PGF. PGF patients without count recovery had a 2 year OS of 6%. Severe GVHD, thrombocytopenia and anemia portended inferior survival and were used to develop a prognostic score for mortality from PGF. This analysis identifies risk factors predictive of PGF and poor survival in those without recovery.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article